Xia Shuli, Lal Bachchu, Tung Brian, Wang Shervin, Goodwin C Rory, Laterra John
Hugo W. Moser Research Institute at Kennedy Krieger, Baltimore, Maryland (S.X., B.L., B.T., S.W., C.R.G., J.L.); Department of Neurology, Johns Hopkins School of Medicine, Baltimore, Maryland (S.X., B.L., C.R.G., J.L.); Department of Neurosurgery, Johns Hopkins School of Medicine, Baltimore, Maryland (C.R.G., J.L.); Department of Oncology, Johns Hopkins School of Medicine, Baltimore, Maryland (J.L.).
Neuro Oncol. 2016 Apr;18(4):507-17. doi: 10.1093/neuonc/nov171. Epub 2015 Aug 27.
Glioblastoma (GBM) is the most frequent and aggressive primary brain tumor in adults. Recent research on cancer stroma indicates that the brain microenvironment plays a substantial role in tumor malignancy and treatment responses to current antitumor therapy. In this work, we have investigated the effect of alterations in brain tumor extracellular matrix tenascin-C (TNC) on brain tumor growth patterns including proliferation and invasion.
Since intracranial xenografts from patient-derived GBM neurospheres form highly invasive tumors that recapitulate the invasive features demonstrated in human patients diagnosed with GBM, we studied TNC gain-of-function and loss-of function in these GBM neurospheres in vitro and in vivo.
TNC loss-of-function promoted GBM neurosphere cell adhesion and actin cytoskeleton organization. Yet, TNC loss-of-function or exogenous TNC had no effect on GBM neurosphere cell growth in vitro. In animal models, decreased TNC in the tumor microenvironment was accompanied by decreased tumor invasion and increased tumor proliferation, suggesting that TNC regulates the "go-or-grow" phenotypic switch of glioma in vivo. We demonstrated that decreased TNC in the tumor microenvironment modulated behaviors of stromal cells including endothelial cells and microglia, resulting in enlarged tumor blood vessels and activated microglia in tumors. We further demonstrated that tumor cells with decreased TNC expression are sensitive to anti-proliferative treatment in vitro.
Our findings suggest that detailed understanding of how TNC in the tumor microenvironment influences tumor behavior and the interactions between tumor cells and surrounding nontumor cells will benefit novel combinatory antitumor strategies to treat malignant brain tumors.
胶质母细胞瘤(GBM)是成人中最常见且侵袭性最强的原发性脑肿瘤。近期对癌症基质的研究表明,脑微环境在肿瘤恶性程度及对当前抗肿瘤治疗的反应中发挥着重要作用。在本研究中,我们探究了脑肿瘤细胞外基质肌腱蛋白-C(TNC)的改变对脑肿瘤生长模式(包括增殖和侵袭)的影响。
由于源自患者的GBM神经球的颅内异种移植形成高度侵袭性肿瘤,重现了被诊断为GBM的人类患者所表现出的侵袭特征,我们在体外和体内研究了这些GBM神经球中TNC的功能获得和功能丧失情况。
TNC功能丧失促进了GBM神经球细胞的黏附以及肌动蛋白细胞骨架的组织。然而,TNC功能丧失或外源性TNC对体外GBM神经球细胞的生长没有影响。在动物模型中,肿瘤微环境中TNC的减少伴随着肿瘤侵袭的降低和肿瘤增殖的增加,这表明TNC在体内调节胶质瘤的“去或生长”表型转换。我们证明,肿瘤微环境中TNC的减少调节了包括内皮细胞和小胶质细胞在内的基质细胞的行为,导致肿瘤血管扩张和肿瘤内小胶质细胞活化。我们进一步证明,TNC表达降低的肿瘤细胞在体外对抗增殖治疗敏感。
我们的研究结果表明,详细了解肿瘤微环境中的TNC如何影响肿瘤行为以及肿瘤细胞与周围非肿瘤细胞之间的相互作用,将有助于制定治疗恶性脑肿瘤的新型联合抗肿瘤策略。